News 27 November, 2023 - 07:46 (CET) Announcement M Related Documents M MA172 Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) 12.5mg/250mg + 75mg - Tablet, Dispersible + Tablet, Dispersible Universal Corporation Ltd Kenya M MA169 Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) 25mg/500mg + 150mg - Tablet, Dispersible + Tablet, Dispersible Universal Corporation Ltd Kenya M HA752 Dolutegravir (sodium)/Lamivudine/Tenofovir disoproxil fumarate 50mg/300mg/300mg - Tablet, Film-coated Celltrion Inc. Republic of Korea
M MA172 Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) 12.5mg/250mg + 75mg - Tablet, Dispersible + Tablet, Dispersible Universal Corporation Ltd Kenya
M MA169 Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) 25mg/500mg + 150mg - Tablet, Dispersible + Tablet, Dispersible Universal Corporation Ltd Kenya
M HA752 Dolutegravir (sodium)/Lamivudine/Tenofovir disoproxil fumarate 50mg/300mg/300mg - Tablet, Film-coated Celltrion Inc. Republic of Korea